^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

Remarkable response to nivolumab in sarcomatoid malignant pleural mesothelioma with high PD-L1

Published date:
02/14/2020
Excerpt:
We report herein a case of sarcomatoid malignant pleural mesothelioma (MPM) with high PD-L1 expression...After the nivolumab treatment, CT showed a significant reduction in pleural tumours with a marked improvement in symptoms.
DOI:
10.1002/rcr2.536